Jeevan Scientific, a company into clinical research, is in the limelight today. The stock opened over 1% higher at Rs.131, only to rise further and hit the 5% UC of the day at Rs.135.95, where it remains frozen, It’s 52-week high is at Rs.141.30.

The company came out with flying colours in the inspection of its clinical pharmacology centre and bio-analytical facilities by Medicines and Healthcare Products Regulatory Agency (MHRA).

Th purpose of this audit was to review the systems and processes involved in Clinical, Quality Assurance, Bio Analytical, Data management, Statistics, Pharmacy IP reconciliation and Medical writing.

The auditors carried out the inspection from 23-Nov-2021 to 30-Nov-2021 and at the closure appreciated the transparency in maintenance of records and the disclosures thereon.

The audit concluded with No critical observations.